永安药业(002365) - 2017年6月15日投资者关系活动记录表

Group 1: Company Expansion and Production Capacity - The company plans to expand its production capacity of taurine from 34,000 tons to 64,000 tons after the new capacity is operational [2][3] - The expansion is driven by the need for increased demand and the upgrading of production technology [2][3] - The company aims to enhance product quality and market share while maintaining its leading position in the taurine industry [3] Group 2: Market Demand and Pricing Strategy - Currently, there is a supply shortage of taurine, leading to continuous price increases [3][4] - The company operates on an order-based production model, with most contracts locking in prices at the time of signing [3][4] - Long-term, the company will strive to maintain price increases to promote healthy industry development, despite having pricing power [3][4] Group 3: Customer Contracts and Sales - The distribution of long-term and short-term contracts is approximately 50% each [4] - Red Bull is one of the company's major clients, with a half-year contract set to expire in July, after which new terms will be negotiated based on market conditions [4] - The company’s epoxy ethane project is currently in production, with one-third used for internal needs and two-thirds for external sales [4]